Coronary slow flow (CSF) is an angiographic phenomenon with specific epidemiologic
characteristics, associated clinical presentation, and prognosis. Although patients with CSF …

The coronary slow flow phenomenon (CSFP) is an important, angiographic entity
characterized by delayed progression of the injected contrast medium through the coronary …

This study aimed to investigate its clinical implications, risk factors, prognosis, and overall
long-term outcomes. Demographic profiles, various clinical characteristics, and clinical …

The coronary slow flow phenomenon (CSFP) is a poorly recognized clinical entity
characterized by delayed distal vessel opacification in the absence of epicardial coronary …

Background The association between coronary slow flow (CSF) and coronary microvascular
dysfunction (CMD) remains unclear. The objective of this study was to evaluate the …

Background Coronary slow flow (CSF) is characterized by normal or near‐normal coronary
arteries with delayed opacification of the distal vasculature that it may cause angina pectoris …

The coronary slow flow phenomenon (CSFP) is common in coronary angiography, however
its impact on left atrial (LA) function is still controversial. This study aims to evaluate the LA …

Background Previous studies have shown that ticagrelor is more effective than clopidogrel in
platelet inhibition. However, this conclusion remains controversial. Therefore, we performed …

Background Adropin is a peptide hormone expressed in coronary artery endothelial cells,
which plays a potential endothelial protective role. We sought to assess whether serum …

Background On the one hand, the primary coronary slow flow phenomenon (CSFP) can
cause recurrence of chest pain, prompting medical examinations and further healthcare …